Skip to main content
Top
Published in: Rheumatology International 3/2006

01-01-2006 | Original Article

Influence of serum folic acid levels on plasma homocysteine concentrations in patients with rheumatoid arthritis

Authors: Arzu Tiftikci, Ali Ozdemir, Ozlem Tarcin, Orhan Tarcin, Nevsun Inanc, Sureyya Sahinoglu, Haner Direskeneli, Sule Yavuz, Fikriye Uras, Yildiz Barut

Published in: Rheumatology International | Issue 3/2006

Login to get access

Abstract

The purpose of this study was to investigate whether negative effects of methotrexate (mtx) on blood homocysteine (hmc) levels can be prevented with the replacement of folic acid. 42 female patients with rheumatoid arthritis (RA) were studied. Patients were separated into two groups according to their treatment status with mtx (group I: 27 patients taking mtx and folic acid; group II: 15 patients not using mtx). The level of hmc was found to be 6.3±2.4 µmol/l in group I and 7.87±3.2 µmol/l in group II (p>0.05). Folic acid levels of group I and II were found to be 21.3±15.9 ng/ml and 8.41±2.86 ng/ml respectively (p<0.001). There was a statistically-significant correlation between age and hmc levels (r=0.386, p=0.012). Negative statistically-significant correlations were observed between folic acid and hmc levels. The effects of mtx on hmc can be prevented with the replacement of folic acid.
Literature
1.
go back to reference Riise T, Jacobsen BK, Gran JT, Haga HJ, Arnesen E (2001) Total mortality is increased in rheumatoid arthritis. A 17-year prospective study. Clin Rheumatol 20(2):123–127PubMed Riise T, Jacobsen BK, Gran JT, Haga HJ, Arnesen E (2001) Total mortality is increased in rheumatoid arthritis. A 17-year prospective study. Clin Rheumatol 20(2):123–127PubMed
2.
go back to reference Wallenberg-Jonsson S, Ohman ML, Dahlqvist SR (1997) Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol 24(3):445–451PubMed Wallenberg-Jonsson S, Ohman ML, Dahlqvist SR (1997) Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol 24(3):445–451PubMed
3.
go back to reference Myllykangas-Luosujarvi R, Aho K (1995) Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol 22(6):1065–1067PubMed Myllykangas-Luosujarvi R, Aho K (1995) Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol 22(6):1065–1067PubMed
4.
go back to reference Pasceri V, Yeh ETH (1999) A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 100:2124–2126 Pasceri V, Yeh ETH (1999) A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 100:2124–2126
5.
go back to reference Park YB, Lee SK, Lee WK, Suh CH, Lee CW, Lee CH, Song CH, Lee J (1999) Lipid profiles in untreated patients with rheumatoid arthritis. J Rheumatol 26(8):1701–1704PubMed Park YB, Lee SK, Lee WK, Suh CH, Lee CW, Lee CH, Song CH, Lee J (1999) Lipid profiles in untreated patients with rheumatoid arthritis. J Rheumatol 26(8):1701–1704PubMed
6.
go back to reference Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S (1999) Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 131(5):363–375PubMed Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S (1999) Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 131(5):363–375PubMed
7.
go back to reference Roubenoff R, Dellaripa P, Nadeau RM, Abad LW, Muldoon BA, Selhub J, Rosenberg IH (1997) Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheum 40(4):718–722PubMed Roubenoff R, Dellaripa P, Nadeau RM, Abad LW, Muldoon BA, Selhub J, Rosenberg IH (1997) Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheum 40(4):718–722PubMed
8.
go back to reference Hernanz A, Plaza A, Martin-Mola E, De Miguel E (1999) Increased plasma levels of homocysteine and other thiol compounds in rheumatoid arthritis women. Clin Biochem 32(1):65–70CrossRefPubMed Hernanz A, Plaza A, Martin-Mola E, De Miguel E (1999) Increased plasma levels of homocysteine and other thiol compounds in rheumatoid arthritis women. Clin Biochem 32(1):65–70CrossRefPubMed
9.
go back to reference Haagsma JC, Blom JH, Van Riel PLCM, Van’t Hof MA, Giesendorf BAJ, van Oppenraaij-Emmerzaal D, van de Putte LBA (1999) Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis 58:79–84PubMed Haagsma JC, Blom JH, Van Riel PLCM, Van’t Hof MA, Giesendorf BAJ, van Oppenraaij-Emmerzaal D, van de Putte LBA (1999) Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis 58:79–84PubMed
10.
go back to reference Brattstrom L, Israelsson B, Lindgarde F, Hultberg B (1988) Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine beta-synthase deficiency. Metabolism 37:175–178CrossRefPubMed Brattstrom L, Israelsson B, Lindgarde F, Hultberg B (1988) Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine beta-synthase deficiency. Metabolism 37:175–178CrossRefPubMed
11.
go back to reference Stehouwer CDA, Weijenber MP, Van den Berg M, Jakobs C, Feskens EJ, Kromhout D (1998) Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men. Arterioscler Thromb Vasc Biol 18:1895–1901PubMed Stehouwer CDA, Weijenber MP, Van den Berg M, Jakobs C, Feskens EJ, Kromhout D (1998) Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men. Arterioscler Thromb Vasc Biol 18:1895–1901PubMed
12.
go back to reference Van Guldener C, Robinson K (2000) Homocysteine and renal disease. Semin Thromb Hemost 26(3):313–324CrossRefPubMed Van Guldener C, Robinson K (2000) Homocysteine and renal disease. Semin Thromb Hemost 26(3):313–324CrossRefPubMed
13.
go back to reference Brattstrom L, Wilcken DE, Ohrvik J, Brudin L (1998) Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the results of meta-analysis. Circulation 98:2520–2526 Brattstrom L, Wilcken DE, Ohrvik J, Brudin L (1998) Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the results of meta-analysis. Circulation 98:2520–2526
14.
go back to reference Broxson EH, Stork LC, Allen RH, Staber SP, Kolhouse JF (1989) Changes in plasma methionine and total homocysteine levels in patients receiving methotrexate infusions. Cancer Res 49(21):5879–5883PubMed Broxson EH, Stork LC, Allen RH, Staber SP, Kolhouse JF (1989) Changes in plasma methionine and total homocysteine levels in patients receiving methotrexate infusions. Cancer Res 49(21):5879–5883PubMed
15.
go back to reference Morgan SL, Baggott JE, Lee JY, Alarcon GS (1998) Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during long-term, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention. J Rheumatol 25(3):441–446PubMed Morgan SL, Baggott JE, Lee JY, Alarcon GS (1998) Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during long-term, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention. J Rheumatol 25(3):441–446PubMed
Metadata
Title
Influence of serum folic acid levels on plasma homocysteine concentrations in patients with rheumatoid arthritis
Authors
Arzu Tiftikci
Ali Ozdemir
Ozlem Tarcin
Orhan Tarcin
Nevsun Inanc
Sureyya Sahinoglu
Haner Direskeneli
Sule Yavuz
Fikriye Uras
Yildiz Barut
Publication date
01-01-2006
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 3/2006
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-004-0546-x

Other articles of this Issue 3/2006

Rheumatology International 3/2006 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.